Synthesis and biological evaluation of S-[11C]methylated mercaptoimidazolde piperazinyl derivatives as potential radioligands for imaging 5-HT1A receptors by positron emission tomography (PET)


Synthesis and biological evaluation of S-[11C]methylated mercaptoimidazolde piperazinyl derivatives as potential radioligands for imaging 5-HT1A receptors by positron emission tomography (PET)

Garcia, R.; Xavier, C.; Paulo, A.; Santos, I.; Knieß, T.; Bergmann, R.; Wüst, F.

The novel 2-mercaptoimidazolde derivatives, 1-[4-((2-methoxyphenyl)-1-piperazinyl)-butyl]-2-mercaptoimidazolde (3) and methyl[4-((2-methoxyphenyl)-1-piperazinyl))butyl] (2-mercapto-1-methylimidazol-5-yl)methanamide (8), were efficiently labelled with 11C through methylation of the thioketone function with [11C]methyl iodide. The resulting radioligands 1-[4-((2-methoxyphenyl)-1-piperazinyl))butyl]-2-thio[11C]-methylimidazole ([11C]9) and methyl [4-((2-methoxyphenyl)-1-piperazinyl))butyl] (2-thio[11C]methyl-1-methylimidazol-5-yl)-methanamide ([11C]10) were synthesized in radiochemical yields of 20 - 30 % (decay-corrected, related to [11C]CO2) at a specific radioactivity of 0.2-0.4 Ci/μmol within 40-45 min including HPLC-purification. The radiochemical purity exceeded 99 %. The reference compounds 9 and 10 were tested in a competitive receptor binding assay to determine their affinity toward the 5-HT1A recptor. Both compounds exhibit excellent sub-nanomolar affinities (IC50 = 0.576 ± 0.008 nM (9); IC50 = 0.86 ± 0.02 nM (10)) for the 5-HT1A receptor while displaying a high selectivity towards the 5-HT2A subtype of receptors (IC50 > 480 nM). By contrast, compound 9 also shows substantial binding for the alpha-adrenergic receptor (IC50 = 3.00 ± 0.02 nM) when compared with compound 10 (IC50 = 54.5 ± 0.6 nM). Preliminary biodistribution studies in rats showed an initial brain uptake of 1.14 ± 0.11 and 0.37 ± 0.04 % ID/g after 5 min, which decreased to 0.18 ± 0.04 and 0.16 ± 0.01 % ID/g after 60 min for compounds [11C]9 and [11C]10, respectively. For both compounds, the cerebellum and rest of the brain uptake are very similar at the different time points. Unlike [11C]9, the radioligand [11C]10 has significant uptake and retention in the adrenal glands. Due to their washout from the brain compounds [11C]9 and [11C]10 seem not to be good condidates as radioligands for imaging 5-HT1A receptors by PET.

Keywords: carbon-11; mercaptoimidazoles; 5-HT1A receptors; piperazines; positron emission tomography

  • Journal of Labelled Compounds and Radiopharmaceuticals 48(2005), 301-315

Permalink: https://www.hzdr.de/publications/Publ-7198